ArticleHIV medicine2025

Blood pressure and metabolic outcomes after efavirenz- or dolutegravir-based therapy started in acute HIV infection.

Phillip Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.